Longeveron Inc. (NASDAQ: LGVN) Stock Information | RedChip

Longeveron Inc. (NASDAQ: LGVN) Listen to this Section


$2.34
-0.1200 ( -4.88% ) 573.3K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Market Data


Open


$2.34

Previous close


$2.46

Volume


573.3K

Market cap


$33.74M

Day range


$2.31 - $2.48

52 week range


$0.77 - $35.60

Insider Ownership Transactions

Total Amount Purchased: -99,874.00 | $ -233,705.16

Date Type Amount Purchased Purchaser
2023-12-26 Sale -12000.00 Baluch Khoso
2023-12-26 Sale -12000.00 Ross Cathy
2023-12-26 Sale -12000.00 LOSORDO DOUGLAS W
2023-12-26 Sale -12000.00 Hare Joshua
2023-12-26 Sale -12000.00 Soffer Rock
2023-12-26 Sale -12000.00 Ungaro Ursula
2023-12-26 Sale -12000.00 Hare Neil E
2023-12-26 Sale -12000.00 PFEFFER JEFFREY
2023-10-04 Sale -3059.00 Agafonova Nataliya
2023-10-04 Sale -815.00 Lehr Paul T

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 06, 2024
4 Insider transactions 1 May 06, 2024
8-k 8K-related 19 Apr 18, 2024
4 Insider transactions 1 Apr 12, 2024
4 Insider transactions 1 Apr 12, 2024
4 Insider transactions 1 Apr 12, 2024
8-k 8K-related 21 Apr 11, 2024
4 Insider transactions 1 Mar 20, 2024
8-k 8K-related 16 Mar 19, 2024
10-k/a Quarterly Reports 22 Mar 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.